1.Cryptolepine suppresses breast adenocarcinoma via inhibition of HIF-1 mediated glycolysis

Zheng, Zhiyuan, Xu,     More...

Zheng, Zhiyuan, Xu, Ting, Liu, Zhiyan, Tian, Wenyue, Jiang, ZhiHong, Zhu, GuoYuan, Li, Ting, Bai, LiPing, Gao, Jin     Less

Biomedicine and Pharmacotherapy[0753-3322], Published 2022, Volume 153,

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2022影響因子:  7.5  发表年影響因子:  7.5 

2.Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation

Cao, D, Chen, D, Xia     More...

Cao, D, Chen, D, Xia, JN, Wang, WY, Zhu, GY, Chen, LW, Zhang, CT, Tan, B, Li, H, Li, YW     Less

BIOMEDICINE & PHARMACOTHERAPY[0753-3322], Published 2022, Volume 155,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2022影響因子:  7.5  发表年影響因子:  7.5 

3.Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity

Cao, Dai, Peng, ShuX     More...

Cao, Dai, Peng, ShuXian, Li, YingWei, Zhu, GuoYuan, Lu, Yan, Yang, Aiping, Chen, Die, Huang, HuiJie, Chen, LiWen     Less

Biomedicine and Pharmacotherapy[0753-3322], Published 2020, Volume 129,

收錄情况： WOS SCOPUS

WOS核心合集引用: 44  2022影響因子:  7.5  发表年影響因子:  6.530 

4.Gossypol overcomes EGFR-TKIs resistance in non-small cell lung cancer cells by targeting YAP/TAZ and EGFR L858R/T790M

Xu, Jian, Cao, Dai,     More...

Xu, Jian, Cao, Dai, Zhu, GuoYuan, Pan, Hao, Li, YingWei     Less

Biomedicine and Pharmacotherapy[0753-3322], Published 2019, Volume 115,

收錄情况： WOS SCOPUS

WOS核心合集引用: 20  2022影響因子:  7.5  发表年影響因子:  4.545